L-Dopa-Decarboxylase (DDC) is a positive prognosticator for breast cancer patients and epinephrine regulates breast cancer cell (MCF7 and T47D) growth in vitro according to their different expression of Gi-protein-coupled receptors

to connected objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
In: International Journal of Molecular Sciences, 21, 24, S. 9565-

Event
Veröffentlichung
(where)
Augsburg
(who)
Universität Augsburg, MDPI AG
(when)
2020
Creator
Tremmel, Eileen
Kuhn, Christina
Kaltofen, Till
Vilsmaier, Theresa
Mayr, Doris
Mahner, Sven
Ditsch, Nina
Jeschke, Udo
Vattai, Aurelia

DOI
10.3390/ijms21249565
URN
urn:nbn:de:bvb:384-opus4-832701
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
25.03.2025, 1:44 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Tremmel, Eileen
  • Kuhn, Christina
  • Kaltofen, Till
  • Vilsmaier, Theresa
  • Mayr, Doris
  • Mahner, Sven
  • Ditsch, Nina
  • Jeschke, Udo
  • Vattai, Aurelia
  • Universität Augsburg, MDPI AG

Time of origin

  • 2020

Other Objects (12)

Immunotherapy: new options in breast cancer treatment

Immunotherapy: new options in breast cancer treatment

Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen

Hochschulschrift

Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1

Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

Breast cancer

Aufsatzsammlung

Breast cancer

Breast cancer

Breast cancer

Breast cancer

Aufsatzsammlung

Breast cancer

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

Related objects